These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32532990)

  • 1. Quantification of ongoing APOBEC3A activity in tumor cells by monitoring RNA editing at hotspots.
    Jalili P; Bowen D; Langenbucher A; Park S; Aguirre K; Corcoran RB; Fleischman AG; Lawrence MS; Zou L; Buisson R
    Nat Commun; 2020 Jun; 11(1):2971. PubMed ID: 32532990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytidine Deaminase APOBEC3A Regulates PD-L1 Expression in Cancer Cells in a JNK/c-JUN-Dependent Manner.
    Zhao K; Zhang Q; Flanagan SA; Lang X; Jiang L; Parsels LA; Parsels JD; Zou W; Lawrence TS; Buisson R; Green MD; Morgan MA
    Mol Cancer Res; 2021 Sep; 19(9):1571-1582. PubMed ID: 34045311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition.
    Buisson R; Lawrence MS; Benes CH; Zou L
    Cancer Res; 2017 Sep; 77(17):4567-4578. PubMed ID: 28698210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient overexpression of exogenous APOBEC3A causes C-to-U RNA editing of thousands of genes.
    Sharma S; Patnaik SK; Kemer Z; Baysal BE
    RNA Biol; 2017 May; 14(5):603-610. PubMed ID: 27149507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOBEC3A cytidine deaminase induces RNA editing in monocytes and macrophages.
    Sharma S; Patnaik SK; Taggart RT; Kannisto ED; Enriquez SM; Gollnick P; Baysal BE
    Nat Commun; 2015 Apr; 6():6881. PubMed ID: 25898173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creating RNA Specific C-to-U Editase from APOBEC3A by Separation of Its Activities on DNA and RNA Substrates.
    Tang G; Xie B; Hong X; Qin H; Wang J; Huang H; Hao P; Li X
    ACS Synth Biol; 2021 May; 10(5):1106-1115. PubMed ID: 33938211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOBEC3A is a prominent cytidine deaminase in breast cancer.
    Cortez LM; Brown AL; Dennis MA; Collins CD; Brown AJ; Mitchell D; Mertz TM; Roberts SA
    PLoS Genet; 2019 Dec; 15(12):e1008545. PubMed ID: 31841499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Analyses Identify APOBEC3A as a Genomic Instability-Associated Immune Prognostic Biomarker in Ovarian Cancer.
    Xu F; Liu T; Zhou Z; Zou C; Xu S
    Front Immunol; 2021; 12():749369. PubMed ID: 34745121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotoxic stress and viral infection induce transient expression of APOBEC3A and pro-inflammatory genes through two distinct pathways.
    Oh S; Bournique E; Bowen D; Jalili P; Sanchez A; Ward I; Dananberg A; Manjunath L; Tran GP; Semler BL; Maciejowski J; Seldin M; Buisson R
    Nat Commun; 2021 Aug; 12(1):4917. PubMed ID: 34389714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring APOBEC3A protein levels in human cancer cells.
    Dananberg A; Maciejowski J
    Methods Cell Biol; 2024; 182():313-327. PubMed ID: 38359985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of gene expression and associated mutation profiles of APOBEC3A, APOBEC3B, REV1, UNG, and FHIT with chemosensitivity of cancer cell lines to drug treatment.
    Vural S; Simon R; Krushkal J
    Hum Genomics; 2018 Apr; 12(1):20. PubMed ID: 29642934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOBEC3A is implicated in a novel class of G-to-A mRNA editing in WT1 transcripts.
    Niavarani A; Currie E; Reyal Y; Anjos-Afonso F; Horswell S; Griessinger E; Luis Sardina J; Bonnet D
    PLoS One; 2015; 10(3):e0120089. PubMed ID: 25807502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression.
    Warren CJ; Westrich JA; Doorslaer KV; Pyeon D
    Viruses; 2017 Aug; 9(8):. PubMed ID: 28825669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling the Enzyme-Substrate Properties for APOBEC3A-Mediated RNA Editing.
    Kim K; Shi AB; Kelley K; Chen XS
    J Mol Biol; 2023 Sep; 435(17):168198. PubMed ID: 37442413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cytidine deaminase APOBEC3A regulates nucleolar function to promote cell growth and ribosome biogenesis.
    McCool MA; Bryant CJ; Abriola L; Surovtseva YV; Baserga SJ
    PLoS Biol; 2024 Jul; 22(7):e3002718. PubMed ID: 38976757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SMC5/6 complex prevents genotoxicity upon APOBEC3A-mediated replication stress.
    Fingerman DF; O'Leary DR; Hansen AR; Tran T; Harris BR; DeWeerd RA; Hayer KE; Fan J; Chen E; Tennakoon M; Meroni A; Szeto JH; Devenport J; LaVigne D; Weitzman MD; Shalem O; Bednarski J; Vindigni A; Zhao X; Green AM
    EMBO J; 2024 Aug; 43(15):3240-3255. PubMed ID: 38886582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA editing enzyme APOBEC3A promotes pro-inflammatory M1 macrophage polarization.
    Alqassim EY; Sharma S; Khan ANMNH; Emmons TR; Cortes Gomez E; Alahmari A; Singel KL; Mark J; Davidson BA; Robert McGray AJ; Liu Q; Lichty BD; Moysich KB; Wang J; Odunsi K; Segal BH; Baysal BE
    Commun Biol; 2021 Jan; 4(1):102. PubMed ID: 33483601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOBEC3A/B-induced mutagenesis is responsible for 20% of heritable mutations in the TpCpW context.
    Seplyarskiy VB; Andrianova MA; Bazykin GA
    Genome Res; 2017 Feb; 27(2):175-184. PubMed ID: 27940951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation, functional impact, and therapeutic targeting of APOBEC3A in cancer.
    Kawale AS; Zou L
    DNA Repair (Amst); 2024 Sep; 141():103734. PubMed ID: 39047499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical analysis of hypermutation by the deoxycytidine deaminase APOBEC3A.
    Love RP; Xu H; Chelico L
    J Biol Chem; 2012 Aug; 287(36):30812-22. PubMed ID: 22822074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.